排序方式: 共有83条查询结果,搜索用时 15 毫秒
1.
Denis A. Mogilenko Oleg Shpynov Prabhakar Sairam Andhey Laura Arthur Amanda Swain Ekaterina Esaulova Simone Brioschi Irina Shchukina Martina Kerndl Monika Bambouskova Zhangting Yao Anwesha Laha Konstantin Zaitsev Samantha Burdess Susan Gillfilan Sheila A. Stewart Marco Colonna Maxim N. Artyomov 《Immunity》2021,54(1):99-115.e12
2.
3.
Katharina Auer Anna Bachmayr-Heyda Stefanie Aust Nyamdelger Sukhbaatar Agnes Teresa Reiner Christoph Grimm Reinhard Horvat Robert Zeillinger Dietmar Pils 《Oncotarget》2015,6(19):17261-17275
In this study we aimed to analyze the biological mechanisms underlying apparently different modes of peritoneal tumor spread in serous ovarian cancer: miliary (widespread, millet-like lesions) versus non-miliary (bigger, exophytically growing implants). Tumor tissues and ascites from 23 chemotherapy naive patients were analyzed by RNA-sequencing and flow cytometry. On the basis of differential gene expression between miliary and non-miliary, gene signatures were developed. A calculated tumor spread factor revealed a significant independent negative impact of miliary spread on overall survival (HR 3.77; CI95 1.14–12.39; p = 0.029) in an independent cohort of 165 serous ovarian cancer patients. Comparing previously published epithelial-mesenchymal transition (EMT) gene signatures, non-miliary spread correlated significantly with a reduced epithelial status. We conclude that serous ovarian cancer is a heterogeneous disease with distinct modes of peritoneal tumor spread, differing not only in clinical appearance, but also in molecular characteristics and outcome.. EMT, peritoneal inflammation status, and therapeutic options are discussed.
Significance
More than half of serous epithelial ovarian cancer patients present with a newly described type of intraperitoneal tumor spread, associated with differences in the inflammation status, activated oncogenic pathways, lack of EMT, and thus reduced overall survival. Both, the diminished immune reaction and the enhanced epithelial and malignant characteristics of the tumor cells open new avenues for therapeutic options and strategies, like Catumaxomab, already in clinical use. 相似文献4.
5.
6.
目的 Eha是一个影响迟缓爱德华菌(Et)胞内生存的转录调控因子,本研究有助于揭示其调控Et抵御酸的分子机制。方法用ATPase抑制剂洛霉素A1抑制巨噬细胞的酸化,菌落计数法比较酸化对野生株和eha基因缺失株胞内存活数目的影响;比较两种细菌在酸性应激实验中存活率的差异;构建pMP220-P_(eha)LacZ质粒,采用β-半乳糖苷酶实验检测eha基因的启动子在不同酸性pH值下和不同培养时间的转录活性;选择Eha转录水平最高的一个酸性pH值和培养时间,分别提取两种细菌RNA,进行RNA-Sequencing;并用qRT-PCR验证其结果。结果野生株ET13在巨噬细胞内和不同pH酸环境中的存活率明显高于缺失株,阻止酸化胞内菌数明显高于未阻止酸化的胞内菌数(P0.05)。对数期细菌pH6.3培养基生长2h,RNA-Sequencing结果表明:eha基因缺失株转录水平和野生株相比,147个差异显著表达的基因(DEGs)(|log2Ratio|≥1),其中113个上调,34个基因下调,qRT-PCR随机抽样,和RNA-Sequencing表达趋势呈强相关。147个基因采用GO数据库进行功能聚类,分成25类,主要涉及细菌加工、定位、代谢、结合、催化、运输、细胞成份;基于KEGG通路的富集分析,有130个可以富集到55条通路中,包括与氨基酸、核苷酸、脂质代谢及铁的转运等路径,涉及基因较多的有双组分系统、ABC转运系统、不同环境中的微生物代谢和次级代谢产物等路径。结论在酸性生存环境,Eha对Et的转录组呈多途径、多基因的适应性的全局性调控。 相似文献
7.
8.
9.
10.